IL126747A0
(en )
1999-08-17
Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
IL132631A0
(en )
2001-03-19
Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
CZ20011270A3
(en )
2001-09-12
Tetrahydrobenzazepine derivatives suitable as modulators of dopamine D3 receptors
PL329725A1
(en )
1999-04-12
Indole derivatives useful as antagonists of endotelin receptor
PL339551A1
(en )
2000-12-18
Derivatives of rezorcin
PL329875A1
(en )
1999-04-12
Derivatives of carbolin
PL329195A1
(en )
1999-03-15
Derivatives of 6-phenylpyridol-2-amine
AU7653700A
(en )
2001-04-24
New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
PL337773A1
(en )
2000-09-11
Derivatives of benzimidazoles
HUP0100870A3
(en )
2002-11-28
Alpha-aminoamide derivatives useful as analgesic agents
AU7284096A
(en )
1997-04-30
Heterocyclically-substituted 1-indole carboxamides as cyclo-oxygenase-2 inhibitors
PL331562A1
(en )
1999-07-19
Derivatives of tetraquinoline as antagonists of eaa
AU6343998A
(en )
1998-09-18
Constitutively activated serotonin receptors
PL330195A1
(en )
1999-04-26
Antagonist of dopamine d4 receptor
GB2329134B
(en )
2001-02-14
Improvements to apparatus
PL311266A1
(en )
1996-02-05
Application of indole derivatives as 5ht1 antagonists
AU4425399A
(en )
1999-12-30
Novel therapeutic agents that modulate 5-ht receptors
IL109632A0
(en )
1994-08-26
Modulators of the function of the tnf receptors
PL330708A1
(en )
1999-05-24
Derivatives of indolydine useful as antagonists of 5-ht-2c receptor
PL334769A1
(en )
2000-03-13
Derivatives of 5-aroylnaphtene
SI1021442T1
(en )
2002-08-31
8-azabicyclo 3.2.1) octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
PL320638A1
(en )
1997-10-13
Antagonists of endothein receptors
PL330796A1
(en )
1999-06-07
Derivatives of indolin useful as antagonists of 5-ht-2c receptor
AU4262799A
(en )
1999-12-06
Tetraisoquinololine derivatives as modulators of dopamine d3 receptors
ZA974026B
(en )
1998-11-25
Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors